Elevance Health Earnings Preview: What to Expect

Analysts anticipate a low double-digit profit dip for the healthcare giant's Q1 2026 earnings report.

Apr. 6, 2026 at 9:58am

Got story updates? Submit your updates here. ›

Elevance Health, Inc. (ELV), a $66.1 billion health benefits company, is expected to report its fiscal first-quarter 2026 earnings before the market opens on April 22. Analysts forecast ELV to post a profit of $10.61 per share, down 11.4% from the year-ago quarter. For the full fiscal year 2026, analysts expect ELV's EPS to decline 14.4% to $25.93, though it's projected to rebound 12.8% to $29.25 in 2027.

Why it matters

Elevance Health's upcoming earnings report will provide insight into the performance of its core Medicaid and Medicare businesses, which have faced ongoing pressures with lower risk-based membership and margin misalignment. The company's ability to improve margins in Medicare and leverage care coordination and analytics to address cost trends will be closely watched by investors.

The details

ELV stock has notably underperformed the broader market, declining 30% over the past 52 weeks compared to a 22% gain in the S&P 500 Index. The company's underperformance is driven by ongoing challenges in its Medicaid and Medicare segments. However, Elevance Health expects margin improvement in Medicare and is focusing on care coordination and analytics to address cost trends.

  • Elevance Health will release its fiscal first-quarter 2026 earnings before the market opens on Wednesday, April 22, 2026.

The players

Elevance Health, Inc.

A $66.1 billion health benefits company that provides health, dental, vision, and pharmacy benefits, as well as life insurance and disability insurance benefits, with a focus on addressing healthcare disparities.

Got photos? Submit your photos here. ›

The takeaway

Elevance Health's upcoming earnings report will be closely watched by investors as the company navigates ongoing pressures in its core Medicaid and Medicare businesses. The company's ability to improve margins and leverage data-driven strategies to address cost trends will be key to its future performance.